Careful selection and testing of antitachycardia devices are necessary to minimize the risks of spurious discharges and arrhythmia acceleration.
Highlights need for meticulous device testing; leaves open optimal sensing strategies for prospective validation.
Sensing difficulties are more common with antitachycardia devices employing atrial rather than ventricular leads, but the consequences are potentially more disastrous with ventricular leads. The problem may be magnified in that the spurious discharge from poor sensing is likely to be asynchronous. Worsening of arrhythmias during termination attempts cannot be totally avoided, but may be minimized if caution and expertise are applied to selection and testing. A device which can reliably terminate a tachyarrhythmia accelerated by a termination attempt is the safest.
No takes yet. Share an insight, caveat, or question.
Debra S. Echt (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: